Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Prisoners co-infected with tuberculosis and HIV: a systematic review.

Edge CL, King EJ, Dolan K, McKee M.

J Int AIDS Soc. 2016 Nov 15;19(1):20960. doi: 10.7448/IAS.19.1.20960. eCollection 2016. Review.

2.

Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe.

Mansfeld M, Skrahina A, Shepherd L, Schultze A, Panteleev AM, Miller RF, Miro JM, Zeltina I, Tetradov S, Furrer H, Kirk O, Grzeszczuk A, Bolokadze N, Matteelli A, Post FA, Lundgren JD, Mocroft A, Efsen A, Podlekareva DN; TB:HIV study group in EuroCoord.

HIV Med. 2015 Oct;16(9):544-52. doi: 10.1111/hiv.12256. Epub 2015 May 11.

3.

Prevalence of smear positive pulmonary tuberculosis among prisoners in North Gondar Zone Prison, northwest Ethiopia.

Moges B, Amare B, Asfaw F, Tesfaye W, Tiruneh M, Belyhun Y, Mulu A, Kassu A.

BMC Infect Dis. 2012 Dec 15;12:352. doi: 10.1186/1471-2334-12-352.

4.

Factors that influence current tuberculosis epidemiology.

Millet JP, Moreno A, Fina L, del Baño L, Orcau A, de Olalla PG, Caylà JA.

Eur Spine J. 2013 Jun;22 Suppl 4:539-48. doi: 10.1007/s00586-012-2334-8. Epub 2012 May 8. Review.

5.

Control of tuberculosis in large cities in developed countries: an organizational problem.

Caylà JA, Orcau A.

BMC Med. 2011 Nov 28;9:127. doi: 10.1186/1741-7015-9-127.

6.

Tuberculosis treatment adherence and fatality in Spain.

Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, Blanquer R, Casals M; Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE).

Respir Res. 2009 Dec 1;10:121. doi: 10.1186/1465-9921-10-121.

7.

Tuberculosis and illicit drug use: review and update.

Deiss RG, Rodwell TC, Garfein RS.

Clin Infect Dis. 2009 Jan 1;48(1):72-82. doi: 10.1086/594126. Review.

8.
9.

Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Fischer B, Haydon E, Rehm J, Krajden M, Reimer J.

J Urban Health. 2004 Sep;81(3):428-47.

10.

Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.

Altice FL, Springer S, Buitrago M, Hunt DP, Friedland GH.

J Urban Health. 2003 Sep;80(3):416-27.

11.

Prevention and treatment of hepatitis C in injection drug users.

Edlin BR.

Hepatology. 2002 Nov;36(5 Suppl 1):S210-9. Review.

12.

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Edlin BR, Seal KH, Lorvick J, Kral AH, Ciccarone DH, Moore LD, Lo B.

N Engl J Med. 2001 Jul 19;345(3):211-5. No abstract available.

13.

When should we delay highly active antiretroviral therapy?

Bangsberg DR, Moss A.

J Gen Intern Med. 1999 Jul;14(7):446-8. No abstract available.

Supplemental Content

Support Center